Syed Karim
Psychiatry · Kansas City, MONPI 1366698060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 1,064 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,064 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Sunovion Pharmaceuticals Inc.$1K
- Tris Pharma Inc$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $7K from 32 others
What the payments were for
- Food & beverage$17,103100%
- Education$660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$431
How this compares
$17,169 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 11 | $39,361 |
| RexultiBrexpiprazole | 18 | $28,249 |
| VraylarCariprazine Hcl | 14 | $22,242 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 36 | $6,155 |
| VyvanseLisdexamfetamine Dimesylate | 15 | $5,994 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 64 | $4,143 |
| Lurasidone Hcl | 11 | $3,930 |
| Bupropion XlBupropion Hcl | 78 | $2,042 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 54 | $1,910 |
| Duloxetine Hcl | 65 | $1,866 |
| Aripiprazole | 79 | $1,789 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 42 | $1,664 |
| Quetiapine Fumarate | 100 | $1,619 |
| Clonazepam | 161 | $1,519 |
| Olanzapine | 52 | $1,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $829 | $39,36111 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $2,208 | $28,24918 claims |
| AbbVieVraylar | $2,869 | $22,24214 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $717 | $5,99415 claims |
| Almatica Pharma LLCSertraline Hcl | $58 | $44965 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Kansas City
- Brian BarashKansas City$856K
- Mark CannonKansas City$19K
- Asim UlusaracKansas City$12K
- Christine TruebloodKansas City$12K
- Kevin KennettKansas City$12K
- Gregory MattingleySaint Charles$4.7M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- Casey ProughLees Summit$615K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.